title: The management of congenital superior conjunctival fornix prolapse.
abstract: OBJECTIVE
  To present the management of bilateral congenital superior fornicial prolapse and provide its up-to-date review of literature.
  
  
  METHODS
  We present the management of congenital bilateral superior fornicial prolapse treated conservatively with topical antibiotics, lubricants and hypertonic saline. One-week, 2-weeks and 1-month follow-up is presented. Results were assessed in terms of reduction of chemosis and eyelid opening. Updated current English peer-reviewed literature was researched.
  
  
  RESULTS
  The superior fornicial prolapse resolved with conservative management within 10 days, resulting in normal eyelid motility at the end of 1 month. At present 61 cases have been reported in English peer-reviewed journals. The proposed etiology is varied. Conservative management with topical medication provides relief.
  
  
  CONCLUSIONS
  Congenital fornicial prolapse is a rare condition. Topical medication provides complete resolution of prolapse. Authors emphasise the need for awareness of condition among ophthalmologists and neonatologists, because of its gruesome appearance.
authors.affiliation: King George's Medical University, Department of Ophthalmology , Lucknow , India.
authors.forename: Apjit Kaur
authors.initials: AK
authors.lastname: Chhabra
authors.forename: Priyanka
authors.initials: P
authors.lastname: Singh
authors.lastname: Manisha
authors.forename: Rolli
authors.initials: R
authors.lastname: Khurana
authors.forename: Khusboo
authors.initials: K
authors.lastname: Srivastav
mesh_terms: D000287:Administration, Topical; D000900:Anti-Bacterial Agents / Q000008:administration & dosage* / Q000627:therapeutic use; D003131:Combined Modality Therapy; D003229:Conjunctival Diseases / Q000151:congenital / Q000188:drug therapy*; D004483:Ectropion / Q000151:congenital / Q000188:drug therapy*; D005143:Eyelids; D005500:Follow-Up Studies; D006801:Humans; D007231:Infant, Newborn; D054327:Lubricants / Q000008:administration & dosage* / Q000627:therapeutic use; D008297:Male; D011391:Prolapse; D012462:Saline Solution, Hypertonic / Q000008:administration & dosage* / Q000627:therapeutic use
chemical_list: D000900:Anti-Bacterial Agents; D054327:Lubricants; D012462:Saline Solution, Hypertonic